From: The survival analysis and oncogenic effects of CFP1 and 14-3-3 expression on gastric cancer
 | CFP1 expression No. | P | 14-3-3 expression No. | P | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 3 | 6 | 9 | 12 | 0 | 3 | 6 | 9 | 12 | |||
Age | ||||||||||||
 ≥ 58 | 2 | 21 | 11 | 4 | 6 | 0.196 | 0 | 14 | 21 | 4 | 5 | 0.012 |
 < 58 | 4 | 12 | 7 | 9 | 8 | 2 | 14 | 7 | 12 | 5 | ||
Sex | ||||||||||||
 Male | 4 | 23 | 12 | 6 | 8 | 0.633 | 1 | 15 | 20 | 9 | 8 | 0.46 |
 Female | 2 | 10 | 6 | 7 | 6 | 1 | 13 | 8 | 7 | 2 | ||
Tumor invasion (T) | ||||||||||||
 T1 | 4 | 11 | 2 | 0 | 0 | 0 | 0 | 7 | 7 | 3 | 0 | 0.576 |
 T2 | 1 | 3 | 3 | 0 | 0 | 0 | 1 | 4 | 0 | 2 | ||
 T3 | 1 | 13 | 7 | 4 | 2 | 1 | 7 | 9 | 6 | 4 | ||
 T4 | 0 | 6 | 6 | 9 | 12 | 1 | 13 | 8 | 7 | 4 | ||
Lymphnode metastasis (N) | ||||||||||||
 N0 | 4 | 21 | 9 | 2 | 1 | 0.001 | 0 | 12 | 18 | 6 | 1 | 0.343 |
 N1 | 1 | 4 | 2 | 3 | 1 | 1 | 4 | 2 | 2 | 2 | ||
 N2 | 1 | 1 | 1 | 2 | 0 | 0 | 2 | 2 | 0 | 1 | ||
 N3 | 0 | 4 | 5 | 2 | 3 | 1 | 5 | 3 | 3 | 2 | ||
 Nx | 0 | 3 | 1 | 4 | 9 | 0 | 5 | 3 | 5 | 4 | ||
Metastasis (M) | ||||||||||||
 M0 | 6 | 30 | 16 | 7 | 5 | 0 | 2 | 22 | 24 | 10 | 6 | 0.266 |
 M1 | 0 | 3 | 2 | 6 | 9 | 0 | 6 | 4 | 6 | 4 | ||
Stage | ||||||||||||
 I | 4 | 13 | 4 | 0 | 0 | 0 | 0 | 7 | 10 | 3 | 1 | 0.242 |
 II | 2 | 11 | 6 | 2 | 2 | 0 | 7 | 10 | 4 | 2 | ||
 III | 0 | 6 | 6 | 5 | 3 | 2 | 8 | 4 | 3 | 3 | ||
 IV | 0 | 3 | 2 | 6 | 9 | 0 | 6 | 4 | 6 | 4 | ||
R0 resection | ||||||||||||
 Yes | 6 | 31 | 17 | 10 | 9 | 0.031 | 2 | 25 | 25 | 14 | 7 | 0.542 |
 No | 0 | 2 | 1 | 3 | 5 | 0 | 3 | 3 | 2 | 3 | ||
Postoperative chemotherapy | ||||||||||||
 Yes | 0 | 13 | 10 | 7 | 6 | 0.155 | 2 | 9 | 12 | 7 | 6 | 0.314 |
 No | 2 | 10 | 0 | 2 | 3 | 0 | 5 | 8 | 4 | 0 | ||
 Uncertain | 4 | 10 | 8 | 4 | 5 | 0 | 14 | 8 | 5 | 4 | ||
Level of differentiation | ||||||||||||
 Well | 0 | 3 | 0 | 1 | 0 | 0.518 | 0 | 3 | 1 | 0 | 0 | 0.761 |
 Middle | 2 | 11 | 4 | 5 | 2 | 1 | 8 | 9 | 4 | 2 | ||
 Poor | 4 | 19 | 14 | 7 | 12 | 1 | 17 | 18 | 12 | 8 |